(Q33305305)

25 July 2017

title

Fenofibrate for diabetic retinopathy. (English)

1 reference

25 July 2017

1 reference

Cristina Hernández

2

1 reference

ORCID Public Data File 2021

author name string

Rafael Simó

series ordinal

1

1 reference

25 July 2017

language of work or name

English

0 references

publication date

7 November 2007

1 reference

25 July 2017

number of pages

2

1 reference

inferred from page(s)

published in

The Lancet

1 reference

25 July 2017

volume

370

1 reference

25 July 2017

issue

9600

1 reference

25 July 2017

page(s)

1667-1668

1 reference

Important Causes of Visual Impairment in the World Today

25 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961608-0

7 January 2021

Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961608-0

7 January 2021

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961608-0

7 January 2021

Proteomic analysis of human vitreous fluid by fluorescence-based difference gel electrophoresis (DIGE): a new strategy for identifying potential candidates in the pathogenesis of proliferative diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961608-0

7 January 2021

Strategies for blocking angiogenesis in diabetic retinopathy: from basic science to clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961608-0

7 January 2021

The effect of ruboxistaurin on visual loss in patients with moderately severe to very severe nonproliferative diabetic retinopathy: initial results of the Protein Kinase C beta Inhibitor Diabetic Retinopathy Study (PKC-DRS) multicenter randomized cl

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961608-0

7 January 2021

Effect of ruboxistaurin on visual loss in patients with diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961608-0

7 January 2021

Effect of ruboxistaurin in patients with diabetic macular edema: thirty-month results of the randomized PKC-DMES clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961608-0

7 January 2021

Clinical update: new treatments for age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961608-0

7 January 2021

10.1016/S0140-6736(07)61608-0

Identifiers

DOI

1 reference

25 July 2017

1 reference